info:eu-repo/semantics/review
Reducing the global burden of HTLV-1 infection: An agenda for research and action
Fecha
2017Institución
Resumen
Even though an estimated 10–20 million people worldwide are infected with the oncogenic retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly understood, and little effort has been made to reduce its prevalence. In response to this situation, the Global Virus Network launched a taskforce in 2014 to develop new methods of prevention and treatment of HTLV-1 infection and promote basic research. HTLV-1 is the etiological agent of two life-threatening diseases, adult T-cell leukemia and HTLV-associated myelopathy/tropical spastic paraparesis, for which no effective therapy is currently available. Although the modes of transmission of HTLV-1 resemble those of the more familiar HIV-1, routine diagnostic methods are generally unavailable to support the prevention of new infections. In the present article, the Taskforce proposes a series of actions to expand epidemiological studies; increase research on mechanisms of HTLV-1 persistence, replication and pathogenesis; discover effective treatments; and develop prophylactic and therapeutic vaccines.
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
High seroprevalence of cytomegalovirus, herpes simplex type 1 virus and epstein barr virus infection among human immunodeficiency virus-infected adults Elevada seroprevalencia de citomegalovirus, virus herpes simplex tipo 1 y virus epstein barr en adultos
Luchsinger, Vivian; Luzoro, Amaranta; Martínez, MaríA José (2010)Background: Cytomegalovirus (CMV), herpes simplex type 1 (HSV-1) and Epstein Barr virus (EBV) are latent persistent infections. Their reactivation may cause illnesses and death in human immunodeficiency virus-infected (HIV) ...